Creutzfeldt Jakob Disease News and Research

RSS
Creutzfeldt–Jakob disease or CJD (sometimes incorrectly referred to as mad cow disease) is a degenerative neurological disorder (brain disease) that is incurable and invariably fatal. It is the most common among the types of transmissible spongiform encephalopathy found in humans.
Researchers match protein to the job it performs in human body

Researchers match protein to the job it performs in human body

Alzheimer's may originate in a form similar to that of infectious prion diseases

Alzheimer's may originate in a form similar to that of infectious prion diseases

Researchers discover several chemical compounds against human prion diseases

Researchers discover several chemical compounds against human prion diseases

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

MAVS prion-like proteins are involved in innate immunity: Discovery

MAVS prion-like proteins are involved in innate immunity: Discovery

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

PrioNet Canada awards University of Western Ontario $600,000 to study neurodegenerative disorders

PrioNet Canada awards University of Western Ontario $600,000 to study neurodegenerative disorders

Researchers identify altered expression of endogenous retroviruses in BSE-infected macaques

Researchers identify altered expression of endogenous retroviruses in BSE-infected macaques

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

Researchers to examine risks and benefits of blood transfusions

Researchers to examine risks and benefits of blood transfusions

Travel, hunting, and venison consumption linked to prion diseases

Travel, hunting, and venison consumption linked to prion diseases

CSEW fails to protect public health by refusing to take part in variant Creutzfeldt-Jakob disease study

CSEW fails to protect public health by refusing to take part in variant Creutzfeldt-Jakob disease study

Baxter's ARTISS phase III study results in face lift surgery presented at AAPS meeting

Baxter's ARTISS phase III study results in face lift surgery presented at AAPS meeting

Welsh CJD alert after two years of exposure

Welsh CJD alert after two years of exposure

CSL Behring presents Hizentra study data against PI at AAAAI meeting

CSL Behring presents Hizentra study data against PI at AAAAI meeting

New research may shed light on possible treatments for prion diseases

New research may shed light on possible treatments for prion diseases

First disease-specific biomarker for sporadic Creutzfeldt-Jakob disease identified

First disease-specific biomarker for sporadic Creutzfeldt-Jakob disease identified

Grifols receives FDA approval for Alphanate to treat vCJD

Grifols receives FDA approval for Alphanate to treat vCJD

FDA approves sBLA for CSL's Hizentra to treat PI

FDA approves sBLA for CSL's Hizentra to treat PI

Aminothiazoles as therapeutic leads for prion diseases

Aminothiazoles as therapeutic leads for prion diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.